Cigna Ventures contributed to a placement for the Express Scripts and Walgreens Boots Alliance-backed turnkey pharmacy service.

The property developer took part in a $68.4m round that will help Juventas advance its clinical-stage oncology cell therapy candidates.

UCL and Francis Crick-founded Achilles has secured $69.9m in its series C round.

Berkeley Catalyst Fund-backed gene therapy developer 4D Molecular Therapeutics withdrew its last attempt in July.

Pfizer Ventures and Chiesi Ventures-backed gene therapy developer 4D Molecular Therapeutics withdrew its last attempt in July.

Aier Eye Hospital was among the participants in a series B-plus round that took the cancer treatment and test developer's overall funding to more than $65m.

Nereid Therapeutics will advance research by Clifford Brangwynne of Princeton University following its launch with a $50m series A round from Apple Tree Partners.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

WuXi AppTec’s Corporate Venture Fund was among the participants in a series A round disclosed as the precision medicine startup emerged from stealth.

The medical social network operator will target chronic disease management startups through the $76.3m fund, formed with Wuhan S&T Investment and China Merchants Bank.